Lack of Specificity of Commercial Antibodies Leads to Misidentification of Angiotensin Type 1 Receptor Protein

Hypertension - United States
doi 10.1161/hypertensionaha.112.203679
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Regulation of Angiotensin II Type 1 Receptor mRNA and Protein in Angiotensin II Induced Hypertension

Hypertension
Internal Medicine
1999English

Divergent Spatiotemporal Interaction of Angiotensin Receptor Blocking Drugs With Angiotensin Type 1 Receptor

English

Polymorphisms of the Angiotensin II Type 1 Receptor Gene Affect Antihypertensive Response to Angiotensin Receptor Blockers in Hypertensive Chinese

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2013English

Lack of Specificity of Antibodies Raised Against CLN3, the Lysosomal/Endosomal Transmembrane Protein Mutated in Juvenile Batten Disease

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2017English

Lack of Serum Antibodies to Native Type II Collagen in Leprosy.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1990English

The Angiotensin II Type 1 Receptor and Receptor-Associated Proteins

Cell Research
Cell BiologyMolecular Biology
2001English

Enhancement of Adipocyte Browning by Angiotensin II Type 1 Receptor Blockade

PLoS ONE
Multidisciplinary
2016English

The Specificity of Monoclonal Anti-Citrulline Protein Antibodies

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2019English

Human Monoclonal Antibodies Block the Binding of SARS-CoV-2 Spike Protein to Angiotensin Converting Enzyme 2 Receptor

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy